The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

Nonfiction, Health & Well Being, Psychology, Psychiatry, Medical, Specialties
Cover of the book The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder by American Psychiatric Association, American Psychiatric Association Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: American Psychiatric Association ISBN: 9780890426838
Publisher: American Psychiatric Association Publishing Publication: January 11, 2018
Imprint: American Psychiatric Association Language: English
Author: American Psychiatric Association
ISBN: 9780890426838
Publisher: American Psychiatric Association Publishing
Publication: January 11, 2018
Imprint: American Psychiatric Association
Language: English

Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality.

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality.

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.

More books from Specialties

Cover of the book Fenichel's Clinical Pediatric Neurology E-Book by American Psychiatric Association
Cover of the book Epilepsy from A - Z by American Psychiatric Association
Cover of the book Therapie der Krankheiten im Kindes- und Jugendalter by American Psychiatric Association
Cover of the book Gallstone Disease by American Psychiatric Association
Cover of the book Medical Management of Type 2 Diabetes by American Psychiatric Association
Cover of the book Addiction Medicine by American Psychiatric Association
Cover of the book Malnutrition in the Elderly by American Psychiatric Association
Cover of the book Adrenal Cortex by American Psychiatric Association
Cover of the book Schein’s Common Sense Emergency Abdominal Surgery by American Psychiatric Association
Cover of the book Postgraduate Orthopaedics by American Psychiatric Association
Cover of the book Glandular Lesions of the Uterine Cervix by American Psychiatric Association
Cover of the book Intensive Care by American Psychiatric Association
Cover of the book Excitatory-Inhibitory Balance by American Psychiatric Association
Cover of the book Imaging and Pathology of Pancreatic Neoplasms by American Psychiatric Association
Cover of the book Atlas of Fetal and Infant Brain MR by American Psychiatric Association
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy